Suppr超能文献

利用电子健康记录估算英格兰各贫困群体中被诊断为老年痴呆症的流行率:一项临床实践研究数据链接研究。

Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink study.

机构信息

Putnam LLC, Toronto, Ontario, Canada.

Global Access, F Hoffmann-La Roche AG, Basel, Switzerland.

出版信息

BMJ Open. 2023 Oct 24;13(10):e075800. doi: 10.1136/bmjopen-2023-075800.

Abstract

OBJECTIVE

Estimate the prevalence of diagnosed Alzheimer's disease (AD) and early Alzheimer's disease (eAD) overall and stratified by age, sex and deprivation and combinations thereof in England on 1 January 2020.

DESIGN

Cross-sectional.

SETTING

Primary care electronic health record data, the Clinical Practice Research database linked with secondary care data, Hospital Episode Statistics (HES) and patient-level deprivation data, Index of Multiple Deprivation (IMD).

OUTCOME MEASURES

The prevalence per 100 000 of the population and corresponding 95% CIs for both diagnosed AD and eAD overall and stratified by covariates. Sensitivity analyses were conducted to assess the sensitivity of the population definition and look-back period.

RESULTS

There were 448 797 patients identified in the Clinical Practice Research Datalink that satisfied the study inclusion criteria and were eligible for HES and IMD linkage. For the main analysis of AD and eAD, 379 763 patients are eligible for inclusion in the denominator. This resulted in an estimated prevalence of diagnosed AD of 378.39 (95% CI, 359.36 to 398.44) per 100 000 and eAD of 292.81 (95% CI, 276.12 to 310.52) per 100 000. Prevalence estimates across main and sensitivity analyses for the entire AD study population were found to vary widely with estimates ranging from 137.48 (95% CI, 127.05 to 148.76) to 796.55 (95% CI, 768.77 to 825.33). There was significant variation in prevalence of diagnosed eAD when assessing the sensitivity with the look-back periods, as low as 120.54 (95% CI, 110.80 to 131.14) per 100 000, and as high as 519.01 (95% CI, 496.64 to 542.37) per 100 000.

CONCLUSIONS

The study found relatively consistent patterns of prevalence across both AD and eAD populations. Generally, the prevalence of diagnosed AD increased with age and increased with deprivation for each age category. Women had a higher prevalence than men. More granular levels of stratification reduced patient numbers and increased the uncertainty of point prevalence estimates. Despite this, the study found a relationship between deprivation and prevalence of AD.

摘要

目的

估计 2020 年 1 月 1 日英格兰总体以及按年龄、性别和贫困程度以及这些因素的组合分层的诊断阿尔茨海默病(AD)和早期阿尔茨海默病(eAD)的患病率。

设计

横断面研究。

设置

初级保健电子健康记录数据、临床实践研究数据库与二级保健数据链接、医院事件统计(HES)和患者层面贫困数据、多因素贫困指数(IMD)。

结局测量

总体以及按协变量分层的诊断 AD 和 eAD 的每 10 万人患病率及其相应的 95%置信区间。进行了敏感性分析以评估人群定义和回溯期的敏感性。

结果

在临床实践研究数据库中识别出 448797 名符合研究纳入标准且有资格进行 HES 和 IMD 链接的患者。对于 AD 和 eAD 的主要分析,379763 名患者有资格计入分母。这导致诊断 AD 的估计患病率为每 100000 人 378.39(95%CI,359.36 至 398.44),eAD 为每 100000 人 292.81(95%CI,276.12 至 310.52)。在整个 AD 研究人群的主要和敏感性分析中,患病率估计值差异很大,范围从 137.48(95%CI,127.05 至 148.76)至 796.55(95%CI,768.77 至 825.33)。当评估回溯期的敏感性时,诊断 eAD 的患病率存在显著差异,低至每 100000 人 120.54(95%CI,110.80 至 131.14),高至每 100000 人 519.01(95%CI,496.64 至 542.37)。

结论

该研究发现 AD 和 eAD 人群的患病率总体上存在相对一致的模式。一般来说,诊断 AD 的患病率随年龄增长而增加,且随每个年龄组的贫困程度增加而增加。女性的患病率高于男性。更细粒度的分层减少了患者人数,并增加了点患病率估计的不确定性。尽管如此,该研究发现了贫困程度与 AD 患病率之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10603427/05f807328d55/bmjopen-2023-075800f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验